Folgen
Oliver Hartley
Oliver Hartley
Bestätigte E-Mail-Adresse bei unige.ch
Titel
Zitiert von
Zitiert von
Jahr
Isolation of high affinity human antibodies directly from large synthetic repertoires.
AD Griffiths, SC Williams, O Hartley, IM Tomlinson, P Waterhouse, ...
The EMBO journal 13 (14), 3245-3260, 1994
13851994
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
L Cartier, O Hartley, M Dubois-Dauphin, KH Krause
Brain Research Reviews 48 (1), 16-42, 2005
5662005
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5
MM Lederman, RS Veazey, R Offord, DE Mosier, J Dufour, M Mefford, ...
Science 306 (5695), 485-487, 2004
4692004
V3: HIV's switch-hitter
O Hartley, PJ Klasse, QJ Sattentau, JP Moore
AIDS Research & Human Retroviruses 21 (2), 171-189, 2005
4012005
Microbicides and other topical strategies to prevent vaginal transmission of HIV
MM Lederman, RE Offord, O Hartley
Nature Reviews Immunology 6 (5), 371-382, 2006
2762006
Characterization of events during the late stages of HPV16 infectionin vivousing high-affinity synthetic fabs to E4
J Doorbar, C Foo, N Coleman, L Medcalf, O Hartley, T Prospero, ...
Virology 238 (1), 40-52, 1997
2201997
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors
O Hartley, H Gaertner, J Wilken, D Thompson, R Fish, A Ramos, ...
Proceedings of the National Academy of Sciences 101 (47), 16460-16465, 2004
1872004
Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots
Z Shulman, SJ Cohen, B Roediger, V Kalchenko, R Jain, V Grabovsky, ...
Nature immunology 13 (1), 67-76, 2012
1792012
A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage.
I Fisch, RE Kontermann, R Finnern, O Hartley, AS Soler-Gonzalez, ...
Proceedings of the National Academy of Sciences 93 (15), 7761-7766, 1996
1611996
NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation
L Serrander, V Jaquet, K Bedard, O Plastre, O Hartley, S Arnaudeau, ...
Biochimie 89 (9), 1159-1167, 2007
1552007
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide
H Gaertner, F Cerini, JM Escola, G Kuenzi, A Melotti, R Offord, ...
Proceedings of the National Academy of Sciences 105 (46), 17706-17711, 2008
1422008
Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab
GJ Beyer, M Miederer, S Vranješ-Đurić, JJ Čomor, G Kuenzi, O Hartley, ...
European journal of nuclear medicine and molecular imaging 31 (4), 547-554, 2004
1222004
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs
VS Torre, AJ Marozsan, JL Albright, KR Collins, O Hartley, RE Offord, ...
Journal of Virology 74 (10), 4868-4876, 2000
1142000
Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES
C Pastore, GR Picchio, F Galimi, R Fish, O Hartley, RE Offord, DE Mosier
Antimicrobial agents and chemotherapy 47 (2), 509-517, 2003
1092003
PSC-RANTES Blocks R5 Human Immunodeficiency Virus Infection of Langerhans Cells Isolated from Individuals with a Variety of CCR5 Diplotypes
T Kawamura, SE Bruce, A Abraha, M Sugaya, O Hartley, RE Offord, ...
Journal of virology 78 (14), 7602-7609, 2004
932004
Targeting chemokine receptors in HIV: a status report
SE Kuhmann, O Hartley
Annu. Rev. Pharmacol. Toxicol. 48, 425-461, 2008
882008
An engineered CX3CR1 antagonist endowed with anti‐inflammatory activity
K Dorgham, A Ghadiri, P Hermand, M Rodero, L Poupel, M Iga, O Hartley, ...
Journal of leukocyte biology 86 (4), 903-911, 2009
872009
The biological effectiveness of antiproton irradiation
MH Holzscheiter, N Bassler, N Agazaryan, G Beyer, E Blackmore, ...
Radiotherapy and Oncology 81 (3), 233-242, 2006
872006
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge
RS Veazey, B Ling, LC Green, EP Ribka, JD Lifson, M Piatak Jr, ...
The Journal of infectious diseases 199 (10), 1525-1527, 2009
832009
Donor-and ligand-dependent differences in CC chemokine receptor 5 reexpression
R Sabbe, GR Picchio, C Pastore, O Chaloin, O Hartley, R Offord, ...
Journal of virology 75 (2), 661-671, 2001
792001
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20